130 Nasal nitric oxide increases in people with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: C. Pioch, S. Graeber, C. Allomba, L. Busack, B. Fuhlrott, A. Schnorr, E. Halver, J. Rohmel, E. Zagkla, M. Yoosefi-Moridani, L. Troltzsch, Z. Syunyaeva, J. Tattersall-Wong, S. Thee, A. Tosolini, N. Ziegahn, M. Mall, M. Stahl Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
131 In vitro responses of F508DEL human nasal epithelial cells correlate with clinical improvement with elexacaftor-tezacaftor-ivacaftor
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: M. Hanafy, C. Fernandez-Petty, R. Joseph, K. Vijaykumar, G. Tearney, S. Rowe, G. Solomon Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
132 Current trends in sputum expectoration and respiratory sampling for research: A single-center experience
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: G. Hong, A. O ’Dea, A. Borowiec, S. Sheikh, D. Dorgan, D. Hadjiliadis Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: C. Wainwright, S. McColley, P. McNally, M. Powers, F. Ratjen, J. Rayment, G. Retsch-Bogart, E. Roesch, N. Ahluwalia, C. Chu, P. Menon, T. Weinstock, J. Davies, for the VX19-445-107 Study Group Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
134 Remote exercise in people with cystic fibrosis: a pilot study using a wearable patch to measure sweat chloride
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: M. Grossman, R. Nelson, Z. Klug, M. Calamari, A. Donayre, T. Cybulski, G. Griffith, D. Corcos, A. Aranyosi, R. Ghaffari, M. Jain Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
135 A multicenter, randomized, controlled trial on coaching and telemonitoring in people with cystic fibrosis (conneCT CF): interim analysis
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: S. Thee, M. Stahl, S. Sutharsan, R. Fischer, M. Ballmann, S. Strasburg, J. Tattersall-Wong, F. Lauer, J. Weitzel, A. Ketter, W. Weber, C. Kittlick, P. Salathe, J. Schiller, F. Puschner, V. Amelung, T. Jacobsen, C. Fuchs, M. Mall Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
136 U.S. research participation and demographic characteristics of people with cystic fibrosis ineligible for CFTR modulators show an imminent need for trial engagement strategies
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: D. Polineni, E. Cromwell, T. Milinic, A. Magaret, C. Goss, J. Clancy, N. Hamblett Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: J. Goralski, C. Daines, J. Pittman, J. Rayment, P. Robinson, R. Thursfield, F. Stehling, F. Ratjen, N. Ahluwalia, C. Chu, P. Menon, T. Weinstock, M. Mall, for the VX20-445-112 Study Group Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
138 Clinical outcomes in people with cystic fibrosis after 2 years of elexacaftor-tezacaftor-ivacaftor: Results from the RECOVER study
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: S. Sutton, P. McNally, K. Lester, B. Elnazir, M. Williamson, D. Cox, B. Linnane, L. Kirwan, P. O ’Regan, G. Stone, C. Saunders, E. McKone, J. Davies Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
139 Comprehension of early cystic fibrosis lung disease or howto TRACK-CF
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: E. Steinke, O. Sommerburg, S. Graeber, C. Joachim, M. Eichinger, M. Wielpuetz, M. Mal, M. Stahl Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
140 Rhinosinusitis outcomes in people with cystic fibrosis after 6 months of elexacaftor-tezacaftor-ivacaftor —Results from the RECOVER study
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: R. Stone, K. Lester, D. Cox, M. Williamson, B. Elnazir, B. Linnane, E. Twomey, T. Persaud, D. Rea, R. Cunney, J. Davies, P. McNally Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
141 Factors associated with significantly corrected sweat chloride in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor —results from the PROMISE and RECOVER studies
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: P. McNally, G. Solomon, D. Nichols, S. Rowe, F. Ratjen, M. Rosenfeld, A. Kelly, L. Kirwan, J. Davies, S. Heltshe Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
142 Elexacaftor-tezacaftor-ivacaftor and spirometry-controlled chest CT scores in children with cystic fibrosis aged 6 to 11
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: K. Lester, P. McNally, J. Davies, B. Elnazir, D. Cox, M. Williamson, B. Linnane, L. Kirwan, P. O ’Regan, E. McKone, E. Twomey, T. Persaud, D. Rea, M. Bonte, H. Tiddens, T. Semple Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
143 High-dose vitamin D treatment of cystic fibrosis pulmonary exacerbations modulates the correlation profile of plasma immune mediators
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: D. Moncada-Giraldo, V. Giacalone, J. Alvarez, C. Margaroli, V. Tangpricha, R. Tirouvanziam Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
144 Changes in airway nitric oxide in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor —Results from the RECOVER study
(Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - October 1, 2023 Category: Respiratory Medicine Authors: K. Lester, P. McNally, J. Davies, B. Elnazir, D. Cox, M. Williamson, B. Linnane, L. Kirwan, P. O ’Regan, E. McKone, H. Grasemann Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research
